Cardiac Biotech Solutions, Inc. (CBSC)
0.035
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Cardiac Biotech Solutions Gross Profit Margin (Quarterly) : 0.00% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00% |
| March 31, 2026 | 0.00% |
| December 31, 2025 | 0.00% |
| September 30, 2025 | 0.00% |
| June 30, 2025 | 0.00% |
| March 31, 2025 | 0.00% |
| December 31, 2024 | 0.00% |
| September 30, 2024 | 0.00% |
| June 30, 2024 | 0.00% |
| March 31, 2024 | 0.00% |
| December 31, 2023 | 0.00% |
| September 30, 2023 | 0.00% |
| June 30, 2023 | 0.00% |
| March 31, 2023 | 62.75% |
| December 31, 2022 | |
| September 30, 2022 | -1.30K% |
| June 30, 2022 | -124.9% |
| March 31, 2022 | -168.5% |
| December 31, 2021 | -4.52K% |
| September 30, 2021 | -751.6% |
| Date | Value |
|---|---|
| June 30, 2021 | -2.84K% |
| March 31, 2021 | 64.15% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | -1.46K% |
| June 30, 2020 | -771.3% |
| March 31, 2020 | 18.12% |
| December 31, 2019 | |
| June 30, 2019 | 0.72% |
| March 31, 2019 | 36.52% |
| December 31, 2018 | -113.9% |
| September 30, 2018 | -609.6% |
| June 30, 2018 | -1.02K% |
| March 31, 2018 | -1.36K% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | -1.71K% |
| June 30, 2017 | -1.15K% |
| March 31, 2017 | -970.5% |
| December 31, 2016 | -1.40K% |
| September 30, 2016 | -910.3% |
| June 30, 2016 | -67.61% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Vyome Holdings, Inc. | 33.33% |
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -213.4% |
| Profit Margin (Quarterly) | -341.3% |
| Operating Margin (Quarterly) | -290.5% |
| Return on Net Operating Assets | -507.2% |